HEADER LYASE 14-OCT-08 3EW4 OBSLTE 11-APR-12 3EW4 4E25 TITLE ALGINATE LYASE A1-III Y246F COMPLEXED WITH ALGINATE TETRASACCHARIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALGINATE LYASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES IN DATABASE 54-404; COMPND 5 SYNONYM: ALGINATE LYASE A1-III; COMPND 6 EC: 4.2.2.3; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SPHINGOMONAS SP.; SOURCE 3 ORGANISM_TAXID: 28214; SOURCE 4 STRAIN: A1; SOURCE 5 GENE: ALY; SOURCE 6 EXPRESSION_SYSTEM: BACILLUS SUBTILIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1423; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PISA412 KEYWDS ALGINATE LYASE, TETRASACCHARIDE COMPLEX, ALPHA BARREL, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR B.MIKAMI,M.BAN,S.SUZUKI,H.J.YOON,O.MIYAKE,M.YAMASAKI,K.OGURA, AUTHOR 2 W.HASHIMOTO,K.MURATA REVDAT 2 11-APR-12 3EW4 1 OBSLTE VERSN REVDAT 1 20-OCT-09 3EW4 0 JRNL AUTH B.MIKAMI,M.BAN,S.SUZUKI,H.J.YOON,O.MIYAKE,M.YAMASAKI, JRNL AUTH 2 K.OGURA,W.HASHIMOTO,K.MURATA JRNL TITL INDUCED FIT MOTION OF THE LID LOOP AND CATALYTIC MECHANISM JRNL TITL 2 OF ALGINATE LYASE A1 III JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 81.7 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.162 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.162 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1643 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 31250 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.134 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 25204 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5610 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 337 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 6043.00 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 21 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 24848 REMARK 3 NUMBER OF RESTRAINTS : 24471 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 0.019 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.021 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.023 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.029 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.013 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.084 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3EW4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-OCT-08. REMARK 100 THE RCSB ID CODE IS RCSB049840. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL38B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33089 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 39.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.3 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.49800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24%(W/V) PEG4000, 0.3M AMMONIUM REMARK 280 ACETATE, 0.1M SODIUM CITRATE, PH 5.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.78050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.83500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.78700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.83500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.78050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.78700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CE1 HIS B 73 CG GLN B 242 1.02 REMARK 500 NE2 HIS B 73 CB GLN B 242 1.67 REMARK 500 NE2 HIS B 73 CG GLN B 242 1.68 REMARK 500 CE1 HIS B 73 CD GLN B 242 2.11 REMARK 500 CE1 HIS B 73 CB GLN B 242 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 7 4.25 -64.19 REMARK 500 SER A 19 -155.37 58.05 REMARK 500 HIS A 73 -169.94 -161.52 REMARK 500 ASN A 190 -156.35 -94.72 REMARK 500 HIS A 240 -122.19 62.43 REMARK 500 THR A 335 -78.79 -93.18 REMARK 500 SER B 19 -155.38 58.04 REMARK 500 PRO B 65 -176.79 -67.79 REMARK 500 TYR B 68 -46.20 -132.36 REMARK 500 LEU B 69 46.54 34.26 REMARK 500 SER B 70 14.83 -162.31 REMARK 500 ASN B 72 105.97 -54.62 REMARK 500 HIS B 73 57.15 76.38 REMARK 500 VAL B 76 118.51 74.45 REMARK 500 ASN B 158 52.30 -101.95 REMARK 500 CYS B 189 -5.01 -141.51 REMARK 500 ASN B 190 -159.84 -98.10 REMARK 500 HIS B 240 -103.53 68.52 REMARK 500 ASP B 267 79.46 -109.73 REMARK 500 ASN B 291 87.70 -178.17 REMARK 500 PHE B 308 56.02 -97.39 REMARK 500 MET B 334 57.08 -96.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 188 CYS A 189 -149.57 REMARK 500 CYS B 188 CYS B 189 -150.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 757 DISTANCE = 5.24 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAW A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEM A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEM A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEM A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAW B 411 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEM B 412 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEM B 413 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEM B 414 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QAZ RELATED DB: PDB REMARK 900 RELATED ID: 1HV6 RELATED DB: PDB REMARK 900 RELATED ID: 3EVH RELATED DB: PDB REMARK 900 RELATED ID: 3EVL RELATED DB: PDB DBREF 3EW4 A 6 356 UNP Q9KWU1 Q9KWU1_9SPHN 54 404 DBREF 3EW4 B 6 356 UNP Q9KWU1 Q9KWU1_9SPHN 54 404 SEQADV 3EW4 GLY A 4 UNP Q9KWU1 EXPRESSION TAG SEQADV 3EW4 SER A 5 UNP Q9KWU1 EXPRESSION TAG SEQADV 3EW4 PHE A 246 UNP Q9KWU1 TYR 294 ENGINEERED SEQADV 3EW4 ALA A 347 UNP Q9KWU1 GLY 395 CONFLICT SEQADV 3EW4 GLY B 4 UNP Q9KWU1 EXPRESSION TAG SEQADV 3EW4 SER B 5 UNP Q9KWU1 EXPRESSION TAG SEQADV 3EW4 PHE B 246 UNP Q9KWU1 TYR 294 ENGINEERED SEQADV 3EW4 ALA B 347 UNP Q9KWU1 GLY 395 CONFLICT SEQRES 1 A 353 GLY SER HIS PRO PHE ASP GLN ALA VAL VAL LYS ASP PRO SEQRES 2 A 353 THR ALA SER TYR VAL ASP VAL LYS ALA ARG ARG THR PHE SEQRES 3 A 353 LEU GLN SER GLY GLN LEU ASP ASP ARG LEU LYS ALA ALA SEQRES 4 A 353 LEU PRO LYS GLU TYR ASP CYS THR THR GLU ALA THR PRO SEQRES 5 A 353 ASN PRO GLN GLN GLY GLU MET VAL ILE PRO ARG ARG TYR SEQRES 6 A 353 LEU SER GLY ASN HIS GLY PRO VAL ASN PRO ASP TYR GLU SEQRES 7 A 353 PRO VAL VAL THR LEU TYR ARG ASP PHE GLU LYS ILE SER SEQRES 8 A 353 ALA THR LEU GLY ASN LEU TYR VAL ALA THR GLY LYS PRO SEQRES 9 A 353 VAL TYR ALA THR CYS LEU LEU ASN MET LEU ASP LYS TRP SEQRES 10 A 353 ALA LYS ALA ASP ALA LEU LEU ASN TYR ASP PRO LYS SER SEQRES 11 A 353 GLN SER TRP TYR GLN VAL GLU TRP SER ALA ALA THR ALA SEQRES 12 A 353 ALA PHE ALA LEU SER THR MET MET ALA GLU PRO ASN VAL SEQRES 13 A 353 ASP THR ALA GLN ARG GLU ARG VAL VAL LYS TRP LEU ASN SEQRES 14 A 353 ARG VAL ALA ARG HIS GLN THR SER PHE PRO GLY GLY ASP SEQRES 15 A 353 THR SER CYS CYS ASN ASN HIS SER TYR TRP ARG GLY GLN SEQRES 16 A 353 GLU ALA THR ILE ILE GLY VAL ILE SER LYS ASP ASP GLU SEQRES 17 A 353 LEU PHE ARG TRP GLY LEU GLY ARG TYR VAL GLN ALA MET SEQRES 18 A 353 GLY LEU ILE ASN GLU ASP GLY SER PHE VAL HIS GLU MET SEQRES 19 A 353 THR ARG HIS GLU GLN SER LEU HIS PHE GLN ASN TYR ALA SEQRES 20 A 353 MET LEU PRO LEU THR MET ILE ALA GLU THR ALA SER ARG SEQRES 21 A 353 GLN GLY ILE ASP LEU TYR ALA TYR LYS GLU ASN GLY ARG SEQRES 22 A 353 ASP ILE HIS SER ALA ARG LYS PHE VAL PHE ALA ALA VAL SEQRES 23 A 353 LYS ASN PRO ASP LEU ILE LYS LYS TYR ALA SER GLU PRO SEQRES 24 A 353 GLN ASP THR ARG ALA PHE LYS PRO GLY ARG GLY ASP LEU SEQRES 25 A 353 ASN TRP ILE GLU TYR GLN ARG ALA ARG PHE GLY PHE ALA SEQRES 26 A 353 ASP GLU LEU GLY PHE MET THR VAL PRO ILE PHE ASP PRO SEQRES 27 A 353 ARG THR GLY GLY SER ALA THR LEU LEU ALA TYR LYS PRO SEQRES 28 A 353 GLN GLY SEQRES 1 B 353 GLY SER HIS PRO PHE ASP GLN ALA VAL VAL LYS ASP PRO SEQRES 2 B 353 THR ALA SER TYR VAL ASP VAL LYS ALA ARG ARG THR PHE SEQRES 3 B 353 LEU GLN SER GLY GLN LEU ASP ASP ARG LEU LYS ALA ALA SEQRES 4 B 353 LEU PRO LYS GLU TYR ASP CYS THR THR GLU ALA THR PRO SEQRES 5 B 353 ASN PRO GLN GLN GLY GLU MET VAL ILE PRO ARG ARG TYR SEQRES 6 B 353 LEU SER GLY ASN HIS GLY PRO VAL ASN PRO ASP TYR GLU SEQRES 7 B 353 PRO VAL VAL THR LEU TYR ARG ASP PHE GLU LYS ILE SER SEQRES 8 B 353 ALA THR LEU GLY ASN LEU TYR VAL ALA THR GLY LYS PRO SEQRES 9 B 353 VAL TYR ALA THR CYS LEU LEU ASN MET LEU ASP LYS TRP SEQRES 10 B 353 ALA LYS ALA ASP ALA LEU LEU ASN TYR ASP PRO LYS SER SEQRES 11 B 353 GLN SER TRP TYR GLN VAL GLU TRP SER ALA ALA THR ALA SEQRES 12 B 353 ALA PHE ALA LEU SER THR MET MET ALA GLU PRO ASN VAL SEQRES 13 B 353 ASP THR ALA GLN ARG GLU ARG VAL VAL LYS TRP LEU ASN SEQRES 14 B 353 ARG VAL ALA ARG HIS GLN THR SER PHE PRO GLY GLY ASP SEQRES 15 B 353 THR SER CYS CYS ASN ASN HIS SER TYR TRP ARG GLY GLN SEQRES 16 B 353 GLU ALA THR ILE ILE GLY VAL ILE SER LYS ASP ASP GLU SEQRES 17 B 353 LEU PHE ARG TRP GLY LEU GLY ARG TYR VAL GLN ALA MET SEQRES 18 B 353 GLY LEU ILE ASN GLU ASP GLY SER PHE VAL HIS GLU MET SEQRES 19 B 353 THR ARG HIS GLU GLN SER LEU HIS PHE GLN ASN TYR ALA SEQRES 20 B 353 MET LEU PRO LEU THR MET ILE ALA GLU THR ALA SER ARG SEQRES 21 B 353 GLN GLY ILE ASP LEU TYR ALA TYR LYS GLU ASN GLY ARG SEQRES 22 B 353 ASP ILE HIS SER ALA ARG LYS PHE VAL PHE ALA ALA VAL SEQRES 23 B 353 LYS ASN PRO ASP LEU ILE LYS LYS TYR ALA SER GLU PRO SEQRES 24 B 353 GLN ASP THR ARG ALA PHE LYS PRO GLY ARG GLY ASP LEU SEQRES 25 B 353 ASN TRP ILE GLU TYR GLN ARG ALA ARG PHE GLY PHE ALA SEQRES 26 B 353 ASP GLU LEU GLY PHE MET THR VAL PRO ILE PHE ASP PRO SEQRES 27 B 353 ARG THR GLY GLY SER ALA THR LEU LEU ALA TYR LYS PRO SEQRES 28 B 353 GLN GLY HET MAW A 401 11 HET BEM A 402 12 HET BEM A 403 12 HET BEM A 404 13 HET MAW B 411 11 HET BEM B 412 12 HET BEM B 413 12 HET BEM B 414 13 HETNAM MAW 4-DEOXY-ALPHA-L-ERYTHRO-HEX-4-ENOPYRANURONIC ACID HETNAM BEM BETA-D-MANNURONIC ACID HETSYN BEM (2S,3S,4S,5S,6R)-3,4,5,6-TETRAHYDROXYOXANE-2-CARBOXYLIC HETSYN 2 BEM ACID FORMUL 3 MAW 2(C6 H8 O6) FORMUL 3 BEM 6(C6 H10 O7) FORMUL 5 HOH *337(H2 O) HELIX 1 1 ASP A 22 GLY A 33 1 12 HELIX 2 2 ASP A 36 LEU A 43 1 8 HELIX 3 3 ASP A 79 GLY A 105 1 27 HELIX 4 4 LYS A 106 ALA A 123 1 18 HELIX 5 5 SER A 133 SER A 151 1 19 HELIX 6 6 THR A 152 MET A 154 5 3 HELIX 7 7 ASP A 160 SER A 180 1 21 HELIX 8 8 ASN A 190 LYS A 208 1 19 HELIX 9 9 ASP A 209 GLY A 225 1 17 HELIX 10 10 HIS A 235 GLU A 241 5 7 HELIX 11 11 GLN A 242 ARG A 263 1 22 HELIX 12 12 ASP A 267 TYR A 271 5 5 HELIX 13 13 ASP A 277 ASN A 291 1 15 HELIX 14 14 PRO A 292 LYS A 297 1 6 HELIX 15 15 ARG A 312 ASP A 314 5 3 HELIX 16 16 LEU A 315 GLY A 326 1 12 HELIX 17 17 ASP A 340 GLY A 344 5 5 HELIX 18 18 SER A 346 TYR A 352 1 7 HELIX 19 19 ASP B 22 SER B 32 1 11 HELIX 20 20 ASP B 36 LEU B 43 1 8 HELIX 21 21 ASP B 79 GLY B 105 1 27 HELIX 22 22 LYS B 106 ALA B 123 1 18 HELIX 23 23 SER B 133 THR B 152 1 20 HELIX 24 24 ASP B 160 PHE B 181 1 22 HELIX 25 25 ASN B 190 SER B 207 1 18 HELIX 26 26 ASP B 209 GLY B 225 1 17 HELIX 27 27 VAL B 234 GLU B 241 5 8 HELIX 28 28 GLN B 242 ARG B 263 1 22 HELIX 29 29 ASP B 277 LYS B 290 1 14 HELIX 30 30 PRO B 292 LYS B 297 1 6 HELIX 31 31 ARG B 312 ASP B 314 5 3 HELIX 32 32 LEU B 315 GLY B 326 1 12 HELIX 33 33 ASP B 340 GLY B 344 5 5 HELIX 34 34 SER B 346 TYR B 352 1 7 SHEET 1 A 2 TYR A 68 SER A 70 0 SHEET 2 A 2 HIS A 73 VAL A 76 -1 O PRO A 75 N LEU A 69 SSBOND 1 CYS A 49 CYS A 112 1555 1555 2.04 SSBOND 2 CYS A 188 CYS A 189 1555 1555 2.03 SSBOND 3 CYS B 49 CYS B 112 1555 1555 2.04 SSBOND 4 CYS B 188 CYS B 189 1555 1555 2.03 LINK C1 MAW A 401 O4 BEM A 402 1555 1555 1.39 LINK C1 BEM A 402 O4 BEM A 403 1555 1555 1.39 LINK C1 BEM A 403 O4 BEM A 404 1555 1555 1.38 LINK C1 MAW B 411 O4 BEM B 412 1555 1555 1.39 LINK C1 BEM B 412 O4 BEM B 413 1555 1555 1.40 LINK C1 BEM B 413 O4 BEM B 414 1555 1555 1.38 SITE 1 AC1 5 GLY A 311 ARG A 312 GLY A 313 BEM A 402 SITE 2 AC1 5 HOH A 523 SITE 1 AC2 10 ARG A 306 ARG A 312 MAW A 401 BEM A 403 SITE 2 AC2 10 HOH A 509 HOH A 523 HOH A 525 HOH A 551 SITE 3 AC2 10 HOH A 648 HOH A 813 SITE 1 AC3 14 ARG A 67 TYR A 68 TYR A 80 ARG A 88 SITE 2 AC3 14 TRP A 141 HIS A 245 PHE A 246 TYR A 249 SITE 3 AC3 14 ARG A 306 ARG A 342 BEM A 402 BEM A 404 SITE 4 AC3 14 HOH A 503 HOH A 509 SITE 1 AC4 9 ARG A 67 GLN A 134 TYR A 137 TRP A 141 SITE 2 AC4 9 ASN A 191 HIS A 192 ARG A 239 PHE A 246 SITE 3 AC4 9 BEM A 403 SITE 1 AC5 3 ARG B 312 GLY B 313 BEM B 412 SITE 1 AC6 8 ARG B 67 ARG B 306 ARG B 312 MAW B 411 SITE 2 AC6 8 BEM B 413 HOH B 522 HOH B 586 HOH B 730 SITE 1 AC7 13 ARG B 67 TYR B 68 TYR B 80 ARG B 88 SITE 2 AC7 13 TRP B 141 HIS B 245 TYR B 249 ARG B 306 SITE 3 AC7 13 ARG B 342 BEM B 412 BEM B 414 HOH B 522 SITE 4 AC7 13 HOH B 730 SITE 1 AC8 9 TYR B 68 ASN B 72 TYR B 137 TRP B 141 SITE 2 AC8 9 ASN B 191 HIS B 192 ARG B 239 PHE B 246 SITE 3 AC8 9 BEM B 413 CRYST1 65.561 77.574 145.670 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015253 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012891 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006865 0.00000